Target Price | JPY8,450.00 |
Price | JPY7,457.00 |
Potential |
13.32%
register free of charge
|
Number of Estimates | 13 |
13 Analysts have issued a price target Chugai Pharmaceutical 2026 .
The average Chugai Pharmaceutical target price is JPY8,450.00.
This is
13.32%
register free of charge
JPY12,000.00
60.92%
register free of charge
JPY6,300.00
15.52%
register free of charge
|
|
A rating was issued by 15 analysts: 7 Analysts recommend Chugai Pharmaceutical to buy, 7 to hold and 1 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Chugai Pharmaceutical stock has an average upside potential 2026 of
13.32%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Revenue Billion JPY | 1,170.61 | 1,213.96 |
5.33% | 3.70% | |
EBITDA Margin | 46.87% | 50.60% |
16.70% | 7.97% | |
Net Margin | 33.09% | 35.57% |
12.98% | 7.51% |
12 Analysts have issued a sales forecast Chugai Pharmaceutical 2025 . The average Chugai Pharmaceutical sales estimate is
This results in the following potential growth metrics:
5 Chugai Pharmaceutical Analysts have issued a net profit forecast 2025. The average Chugai Pharmaceutical net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share JPY | 235.36 | 262.37 |
18.99% | 11.48% | |
P/E | 28.42 | |
EV/Sales | 9.45 |
5 Analysts have issued a Chugai Pharmaceutical forecast for earnings per share. The average Chugai Pharmaceutical EPS is
This results in the following potential growth metrics and future valuations:
Chugai Pharmaceutical...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.